Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CID-103 |
Trade Name | |
Synonyms | CID 103|CID103 |
Drug Descriptions |
CID-103 is a monoclonal antibody that binds CD38, a cell surface glycoprotein expressed on tumor cells, potentially resulting in antibody-dependent cellular cytotoxicity (ADCC) and tumor cell lysis (NCI Drug Dictionary). |
DrugClasses | CD38 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C179660 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CID-103 | CID-103 | 0 | 1 |